Nine Square Therapeutics is discovering new small-molecule therapeutics for degenerative movement disorders including Parkinson’s disease and amyotrophic lateral sclerosis (ALS), as well as non-degenerative disorders such as essential tremor and dyskinesias, by integrating computational chemistry, biophysics, and computational biology intomachine-learning-enabled cell profiling platforms for target identification, chemical optimization, and patient stratification.It was founded in 2020 and headquartered in New York, United States.

Therapeutics

Biotechnology

Nine Square Therapeutics

Robert Paul

Sethu Sankaranarayanan

Tina Schwabe

Steve Altschuler

Mark Rosen

Kristine Anne Gordon

Research and Development

Leadership Team

Teams at Nine Square Therapeutics

Research and Development

Leadership Team